Marta Helena Branquinha de Sá
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Instituto de Microbiologia
Departamento:
Departamento de Microbiologia Geral/IM
Formação:
-
Universidade Federal do Rio de Janeiro
Ciências (Microbiologia) | Doutorado | 1994 - 2000
-
Universidade Federal do Rio de Janeiro
Ciências (Microbiologia) | Mestrado | 1992 - 1994
-
Universidade Federal do Rio de Janeiro
Farmácia | Graduação | 1987 - 1990
Laboratórios:
Nuvens de Palavras:
Artigos:
(41.95% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| Mn(II), Cu(II) and Ag(I) complexes containing 1,10-phenanthroline/1,10-phenanthroline-5,6-dione against Candida species | 2024 | |
| The Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds | 10.3390/pathogens12010070 | 2023 |
| Cell dispersion during biofilm formation by Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum and Lomentospora prolificans | 10.1016/j.crmicr.2023.100191 | 2023 |
| Scedosporium/Lomentospora Species Induce the Production of Siderophores by Pseudomonas aeruginosa in a Cystic Fibrosis Mimic Environment | 10.3390/jof9050502 | 2023 |
| In Vitro Effects of Aminopyridyl Ligands Complexed to Copper(II) on the Physiology and Interaction Process of Trypanosoma cruzi | 10.3390/tropicalmed8050288 | 2023 |
| Paving the way to an antivirulence strategy against fungal pathogens: lessons learned from Candida albicans. | 2023 | |
| Active Cu(II), Mn(II) and Ag(I) 1,10-phenanthroline/1,10-phenanthroline-5,6-dione/dicarboxylate chelates on Scedosporium. | 2023 | |
| Fibronectin-binding molecules of Scedosporium apiospermum: focus on adhesive events | 10.1007/s42770-023-01062-7 | 2023 |
| Cell Aggregation Capability of Clinical Isolates from Candida auris and Candida haemulonii Species Complex | 10.3390/tropicalmed8080382 | 2023 |
| Chagas Disease Control-Many Approaches to Prospect | 10.3390/tropicalmed8080395 | 2023 |
| Development of Echinocandin Resistance in Candida haemulonii: An Emergent, Widespread, and Opportunistic Fungal Pathogen | 10.3390/jof9080859 | 2023 |
| Antifungal potential of the new copper(II)-theophylline/1,10-phenanthroline complex against drug-resistant Candida species | 10.1007/s10534-023-00549-y | 2023 |
| Therapeutic Strategies against Leishmania and Trypanosoma | 10.3390/pathogens12101263 | 2023 |
| Silver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin) | 10.3390/tropicalmed8070348 | 2023 |
| SARS-CoV-2 Post-Infection and Sepsis by Saccharomyces cerevisiae: A Fatal Case Report-Focus on Fungal Susceptibility and Potential Virulence Attributes | 10.3390/tropicalmed8020099 | 2023 |
| Copper(II) and silver(I)-1,10-phenanthroline-5,6-dione complexes interact with double-stranded DNA: further evidence of their apparent multi-modal activity towards Pseudomonas aeruginosa. | 2022 | |
| The enhanced expression of cruzipain-like molecules in the phytoflagellate Phytomonas serpens recovered from the invertebrate and plant hosts. | 2022 | |
| A stroll through the history of monoxenous trypanosomatids infection in vertebrate hosts. | 2022 | |
| Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B | 10.3390/tropicalmed7020029 | 2022 |
| Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the genera | 10.1093/mmy/myac036 | 2022 |
| Prospective Medicines against the Widespread, Emergent and Multidrug-Resistant Opportunistic Fungal Pathogen Candida auris: A Breath of Hope. | 10.2174/1568026622666220520153748 | 2022 |
| Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors | 10.1590/0074-02760220017 | 2022 |
| Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors | 10.1590/0074-02760210386 | 2022 |
| The Threat Called Candida haemulonii Species Complex in Rio de Janeiro State, Brazil: Focus on Antifungal Resistance and Virulence Attributes | 10.3390/jof8060574 | 2022 |
| Differences in Charge Distribution in Leishmania tarentolae Leishmanolysin Result in a Reduced Enzymatic Activity | 10.3390/ijms23147660 | 2022 |
| Extracellularly Released Molecules by the Multidrug-Resistant Fungal Pathogens Belonging to the Scedosporium Genus: An Overview Focused on Their Ecological Significance and Pathogenic Relevance | 10.3390/jof8111172 | 2022 |
| Decoding the anti-Leishmania braziliensis activity of 1,10-phenanthroline-5,6-dione and its silver- and copper-based complexes: In vitro and in vivo approaches | 10.1016/j.ejmcr.2022.100093 | 2022 |
| Halobacillus blutaparonensis strain M9 as a source of extracellular serine peptidases with properties for biotechnological purposes | 2021 | |
| Azithromycin use in COVID-19 patients: implications on the antimicrobial resistance | 2021 | |
| Physical stability enhancement and antimicrobial properties of a sodium ionic cocrystal with theophylline | 2021 | |
| Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment. | 2021 | |
| The serine peptidase inhibitor N-ρ-tosyl-L-phenylalanine chloromethyl ketone (TPCK) affects cell biology of Candida haemulonii species complex. | 2021 | |
| The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity? | 10.3390/cells10020299 | 2021 |
| Overcoming multi-resistant leishmania treatment by nanoencapsulation of potent antimicrobials | 10.1002/jctb.6633 | 2021 |
| In vitro effects of bis(N-[4-(hydroxyphenyl)methyl]-2-pyridinemethamine)zinc perchlorate monohydrate 4 on the physiology and interaction process of Leishmania amazonensis | 10.1016/j.parint.2021.102376 | 2021 |
| Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches | 10.3390/jof7060424 | 2021 |
| Protease inhibitors as promising weapons against COVID-19: focus on repurposing of drugs used to treat HIV and HCV infections | 2021 | |
| Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Trypanosoma cruzi and Inhibit Both Aspartyl-Type Peptidase and Cruzipain Activities Detected in These Crucial Organelles | 10.3390/tropicalmed6030120 | 2021 |
| Analysis of the mechanisms of action of isopentenyl caffeate against Leishmania | 10.1016/j.biochi.2021.06.015 | 2021 |
| Anti-Leishmania braziliensis activity of 1,10-phenanthroline-5,6-dione and its Cu(II) and Ag(I) complexes | 10.1007/s00436-021-07265-x | 2021 |
| Silver(I) and Copper(II) Complexes of 1,10-Phenanthroline-5,6-Dione Against Phialophora verrucosa: A Focus on the Interaction With Human Macrophages and Galleria mellonella Larvae | 10.3389/fmicb.2021.641258 | 2021 |
| Insights into the interaction of Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporiun minutisporum and Lomentospora prolificans with lung epithelial cells | 2020 | |
| In vivo Activity of Copper(II), Manganese(II), and Silver(I) 1,10-Phenanthroline Chelates Against Candida haemulonii Using the Galleria mellonella Model | 10.3389/fmicb.2020.00470 | 2020 |
| Biofilm Formed by Candida haemulonii Species Complex: Structural Analysis and Extracellular Matrix Composition | 10.3390/jof6020046 | 2020 |
| Unmasking the amphotericin B resistance mechanisms in Candida haemulonii species complex | 10.1021/acsinfecdis.0c00117 | 2020 |
| Surface, adhesiveness and virulence aspects of Candida haemulonii species complex | 10.1093/mmy/myz139 | 2020 |
| Biofilms formed by Scedosporium and Lomentospora species: focus on the extracellular matrix | 10.1080/08927014.2020.1759558 | 2020 |
| Funding for Chagas Disease: A 10-Year (2009-2018) Survey | 10.3390/tropicalmed5020088 | 2020 |
| Analyzing ambiguities in trypanosomatids taxonomy by barcoding | 2020 | |
| Secreted aspartyl peptidases by the emerging, opportunistic and multidrug-resistant fungal pathogens comprising the Candida haemulonii complex. | 2020 | |
| Drug repurposing strategy against fungal biofilms | 2020 | |
| Saccharide sources do not influence the biofilm formation in Scedosporium/Lomentospora species | 2020 | |
| Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options | 10.2174/156802662022200917110102 | 2020 |
| β-Cyclodextrin/Isopentyl Caffeate Inclusion Complex: Synthesis, Characterization and Antileishmanial Activity | 10.3390/molecules25184181 | 2020 |
| Susceptibility of the Candida haemulonii Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review | 10.3390/jof6040201 | 2020 |
| Insights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex | 10.3390/jof6040215 | 2020 |
| Expression and cellular localisation of Trypanosoma cruzi calpains | 10.1590/0074-02760200142 | 2020 |
| Candida albicans isolated from denture-related stomatitis in elderly patients: Antifungal susceptibility and production of virulence attributes | 10.1017/exp.2020.49 | 2020 |
| Participation of Trypanosoma cruzi gp63 molecules on the interaction with Rhodnius prolixus | 10.1017/s0031182019000441 | 2019 |
| Leishmaniasis and Chagas Disease - Neglected Tropical Diseases: Treatment Updates | 10.2174/156802661903190328155136 | 2019 |
| The serine peptidase inhibitor TPCK induces several morphophysiological changes in the opportunistic fungal pathogen Candida parapsilosis sensu stricto | 10.1093/mmy/myz008 | 2019 |
| Anti-Virulence Strategy against the Multidrug-Resistant Bacterial Pathogen Pseudomonas aeruginosa: Pseudolysin (Elastase B) as a Potential Druggable Target | 10.2174/1389203720666190207100415 | 2019 |
| Insights into the social life and obscure side of Scedosporium/Lomentospora species: ubiquitous, emerging and multidrug-resistant opportunistic pathogens | 10.1016/j.fbr.2018.07.002 | 2019 |
| Current challenges and updates on therapy of fungal infections | 2019 | |
| Miltefosine-lopinavir combination therapy against Leishmania infantum infection: in vitro and in vivo approaches | 2019 | |
| Chymotrypsin- and trypsin-like activities secreted by the fungal pathogens forming the Candida haemulonii complex | 2019 | |
| Repositioning of HIV aspartyl peptidase inhibitors for combating the neglected human pathogen Trypanosoma cruzi | 2019 | |
| New and promising chemotherapeutics for emerging infections involving drug-resistant non-albicans Candida species | 2019 | |
| Calpains of Leishmania braziliensis: genome analysis, differential expression, and functional analysis | 10.1590/0074-02760190147 | 2019 |
| Disarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target | 10.3389/fmicb.2019.01701 | 2019 |
| In vitro effects of the asymmetric peptidomimetic 157, containing l-tartaric acid core and valine/leucine substituents, on Leishmania amazonensis promastigotes and amastigotes | 10.1016/j.parint.2019.101968 | 2019 |
| Hydrolytic enzymes (proteases and lipases) released by biofilm-forming cells of Scedosporium/Lomentospora species | 2019 | |
| Asymmetric peptidomimetics containing L-tartaric acid core inhibit the aspartyl peptidase activity and growth of Leishmania amazonensis promastigotes | 10.1515/ap-2018-0013 | 2018 |
| In vitro selection of Phytomonas serpens cells resistant to the calpain inhibitor MDL28170: alterations in fitness and expression of the major peptidases and efflux pumps | 10.1017/s0031182017001561 | 2018 |
| Primary evidences of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms | 2018 | |
| Novel antimony( ) hydroxamic acid complexes as potential anti-leishmanial agents | 10.1039/C8DT00546J | 2018 |
| What are the advantages of living in a community? A microbial biofilm perspective! | 10.1590/0074-02760180212 | 2018 |
| Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species | 10.1093/femsyr/foy082 | 2018 |
| Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum and Lomentospora prolificans: a comparative study of surface molecules produced by conidial and germinated conidial cells | 10.1590/0074-02760180102 | 2018 |
| Ultrastructural viewpoints on the interaction events of Scedosporium apiospermum conidia with lung and macrophage cells | 10.1590/0074-02760180311 | 2018 |
| Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase | 10.1186/s13104-018-3927-z | 2018 |
| Identification of cell-associated and secreted serine-type peptidases in multidrug-resistant emergent pathogens belonging to the Candida haemulonii complex | 10.1007/s12223-018-0651-y | 2018 |
| Susceptibility of promastigotes and intracellular amastigotes from distinct Leishmania species to the calpain inhibitor MDL28170 | 10.1007/s00436-018-5894-7 | 2018 |
| Surface properties, adhesion and biofilm formation on different surfaces by Scedosporium spp. and Lomentospora prolificans | 10.1080/08927014.2018.1503652 | 2018 |
| Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes | 10.1017/s0031182018000823 | 2018 |
| Pseudolysin (elastase B): a protagonist in the Pseudomonas aeruginosa pathogenesis. | 2018 | |
| Susceptibility of Phytomonas serpens to calpain inhibitors in vitro: interference on the proliferation, ultrastructure, cysteine peptidase expression and interaction with the invertebrate host | 2017 | |
| The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi | 2017 | |
| Planktonic growth and and biofilm formation profiles in Candida haemulonii species complex | 2017 | |
| Fungal biofilm - a real obstacle against an efficient therapy: lessons from Candida | 2017 | |
| Old drugs × new perspectives/new compounds × old necessities: focusing on combating microbial resistance - Part I | 2017 | |
| Heterogeneous production of proteases from Brazilian clinical isolates of Pseudomonas aeruginosa | 2017 | |
| Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis? | 2017 | |
| Old drugs × new perspectives/new compounds × old necessities: focusing on combating microbial resistance - Part II | 2017 | |
| Glycosylated metal chelators as anti-parasitic agents with tunable selectivity | 10.1039/C6DT04615K | 2017 |
| Deciphering the effects of nelfinavir and lopinavir on epimastigote forms of Trypanosoma cruzi | 10.1016/j.parint.2017.03.009 | 2017 |
| Different classes of hydrolytic enzymes produced by multidrug-resistant yeasts comprising the Candida haemulonii complex | 10.1093/mmy/myw065 | 2017 |
| Antifungal potential of copper(II), manganese(II) and silver(I) 1,10-phenanthroline chelates against multidrug-resistant fungal species forming the Candida haemulonii complex: impact on the planktonic and biofilm lifestyles | 2017 | |
| The potent cell permeable calpain inhibitor MDL28170 affects the interaction of Leishmania amazonensis with macrophages and shows anti-amastigote activity | 2017 | |
| Trichosporon asahii secretes a 30-kDa aspartic peptidase | 10.1016/j.micres.2017.08.015 | 2017 |
| Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells | 2016 | |
| Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans | 2016 | |
| Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles | 2016 | |
| HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi | 10.1016/j.ijantimicag.2016.06.024 | 2016 |
| Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity | 10.1016/j.ijantimicag.2016.09.017 | 2016 |
| Detection of proteases from Sporosarcina aquimarina and Algoriphagus antarcticus isolated from Antarctic soil | 2015 | |
| Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil | 2015 | |
| Editorial (Thematic Issue: New Antimicrobial Therapeutics) | 10.2174/0929867322666150608093816 | 2015 |
| Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi | 10.2174/0929867322666150521091652 | 2015 |
| Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: species distribution, antifungal susceptibility and virulence attributes | 2015 | |
| Expression of calpain-like proteins and effects of calpain inhibitors on the growth rate of Angomonas deanei wild type and aposymbiotic strains | 10.1186/s12866-015-0519-0 | 2015 |
| Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa | 2014 | |
| Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model | 10.1371/journal.pone.0113957 | 2014 |
| The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes | 2014 | |
| Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil | 10.1093/jac/dku321 | 2014 |
| Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy | 2013 | |
| Proteolytic inhibitors: implications on microorganism development, virulence and pathogenesis. | 2013 | |
| Calpains: potential targets for alternative chemotherapeutic intervention against human pathogenic trypanosomatids. | 2013 | |
| Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients | 10.1093/jac/dks410 | 2013 |
| Differential expression of cruzipain- and gp63-like molecules in the phytoflagellate trypanosomatid Phytomonas serpens induced by exogenous proteins | 2012 | |
| Multiple effects of pepstatin A on Trypanosoma cruzi | 2012 | |
| Antimicrobial action of chelating agents: repercussions on the microorganism development, virulence and pathogenesis. | 2012 | |
| Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut | 2012 | |
| MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut | 2011 | |
| Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes | 2011 | |
| Leishmanolysin-like molecules in Herpetomonas samuelpessoai mediate hydrolysis of protein substrates and interaction with insect | 2010 | |
| Biological roles of peptidases in trypanosomatids | 2010 | |
| Detection of matrix metallopeptidase-9-like proteins in Trypanosoma cruzi | 2010 | |
| Effects of the calpain inhibitor MDL28170 on the clinical relevant forms of Trypanosoma cruzi in vitro | 2010 | |
| Influence of leishmanolysin-like molecules of Herpetomonas samuelpessoai on the interaction with macrophages | 2010 | |
| Differential influence of gp63-like molecules in three distinct Leptomonas species on the adhesion to insect cells. | 2009 | |
| Cysteine peptidases in Herpetomonas samuelpessoai are modulated by temperature and dimethylsulfoxide-triggered differentiation | 2009 | |
| Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms | 2009 | |
| HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis | 2009 | |
| Roles of the endosymbiont and leishmanolysin-like molecules expressed by Crithidia deanei in the interaction with mammalian fibroblasts | 2009 | |
| Bodo sp., a free-living flagellate, expresses divergent proteolytic activities from the closely related parasitic trypanosomatids | 2009 | |
| Sialoglycoconjugates in Herpetomonas megaseliae: role in the adhesion to insect host epithelial cells | 2009 | |
| Cysteine peptidases from Phytomonas serpens:biochemical and immunological approaches | 2009 | |
| Crithidia deanei: influence of parasite gp63 homologue on the interaction of endosymbiont-harboring and aposymbiotic strains with Aedes aegypti midgut | 2008 | |
| Analysis of peptidases in non-infected and Trypanosoma cruzi-infected mouse embryo hepatocyte cells | 2008 | |
| Cysteine peptidases in the tomato trypanosomatid Phytomonas serpens: influence of growth conditions, similarities with cruzipain and secretion to the extracellular environment | 2008 | |
| Trypanosomatid peptidases: a target for drugs development | 2007 | |
| Phytomonas serpens: immunological similarities with the human trypanosomatid pathogens ? a review | 2007 | |
| Peptidases and gp63-like proteins in Herpetomonas megaseliae: possible involvement in the adhesion to the invertebrate host | 2006 | |
| Phytomonas serpens: cysteine protease inhibitors interfere with growth, ultrastructure and host adhesion. | 2006 | |
| Insights into the role of gp63-like proteins in lower trypanosomatids | 2006 | |
| Gp63-like molecules in Phytomonas serpens: possible role on the insect interaction | 2006 | |
| The ubiquitous gp63-like metalloprotease from lower trypanosomatids: in the search for a function | 2006 | |
| Antileishmanial activity of MDL 28170, a potent calpain inhibitor | 2006 | |
| Proteolytic expression in Blastocrithidia culicis: influence of the endosymbiont and similarities with virulence factors of pathogenic trypanosomatids | 2005 | |
| Production and partial characterisation of extracellular proteinases from Streptomyces malaysiensis, isolated from a Brazilian cerrado soil | 2005 | |
| Influence of the endosymbiont of Blastocrithidia culicis and Crithidia deanei on the glycoconjugate expression and on Aedes aegypti interaction | 2005 | |
| Reduced activity of matrix metalloproteinase-9 in Trypanosoma cruzi-infected mouse embryo hepatocyte cell | 2004 | |
| Differential lectin recognition of glycoproteins in choanomastigote-shaped trypanosomatids: taxonomic implications | 2004 | |
| Proteolytic activities in Trypanosoma rangeli and stercorarian trypanosomes: taxonomic implications | 2004 | |
| Extracellular metalloproteinases in Phytomonas serpens | 2003 | |
| Extracellular metalloproteinase activity in Phytomonas françai | 2003 | |
| A novel extracellular calcium-dependent cysteine proteinase from Crithidia deanei | 2003 | |
| A metalloproteinase extracellularly released by Crithidia deanei | 2003 | |
| Crithidia guilhermei: gelatin- and haemoglobin-degrading extracellular metalloproteinases | 2002 | |
| Crithidia guilhermei: purification and partial characterization of a 62-kDa extracellular metalloproteinase | 2001 | |
| Differential expression of proteolytic enzymes in endosymbiont-harboring Crithidia species | 2001 | |
| Identification and properties of two extracellular proteases from Brevundimonas diminuta | 2000 | |
| Influence of growth medium in proteinase and pigment production by Streptomyces cyaneus | 1999 | |
| Structural studies on polar glycoinositol phospholipids of Trypanosoma (Schizotrypanum) dionisii from bats | 1999 | |
| Purification and partial characterization of an extracellular serine-proteinase of Streptomyces cyaneus, isolated from Brazilian cerrado soil | 1999 | |
| Extracelular serine-proteinases isolated from Streptomyces alboniger : partial characterization and effect of aprotinin on cellular structure | 1999 | |
| Ubiquity of cysteine- and metalloproteinases activities in a wide range of trypanosomatids. | 1996 | |
| Monohexosylceramides of Trypanosoma dionisii | 1996 | |
| Detection of extracellular proteases from microorganisms on agar plates. | 1996 | |
| Use of glycoconjugates for trypanosomatid taxonomy | 1995 | |
| Glycolipid and protein profile in trypanosomatids | 1994 | |
| Characterization of proteinases in trypanosomatids | 1994 | |
| Characterizaton of proteinases in trypanosomatids | 1994 |
Eventos:
(0.00% eventos com DOI)